Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2009 Aug 3;10:2–5. doi: 10.1016/S1526-0542(09)70003-X

The year in review

Anne Greenough 1,*
PMCID: PMC7128739  PMID: 19651389

SUMMARY

Over the last year there have been more studies determining predisposition to severe bronchiolitis and its consequences. Studies have highlighted various single-nucleotide polymorphisms (SNPs) to be significantly associated with respiratory syncytial virus (RSV) hospitalisation, and a candidate gene approach demonstrated that innate immune gene SNPs had the strongest association with bronchiolitis. The impact of ‘other’ viruses (RSV, influenza, adenovirus, parainfluenza, rhinovirus, human metapneumovirus [hMPV], coronavirus, boca-virus, enterovirus, paraechovirus) has been investigated. In one series only children with RSV infection experienced recurrent wheezing and in another only RSV infection was associated with respiratory complications (hypoxia correlated with prolonged hospitalisation). Others have examined the long-term outcome of viral infection in infancy. The above studies and others published in the last year will be discussed.

Keywords: RSV, Respiratory syncytial virus, Bronchiolitis, Hospitalisation

REFERENCES

  • 1.Thomsen SF, Stensballe LG, Skytthe A, Kyvik KO, Backer V, Bisgaard H. Increased concordance of severe respiratory syncytial virus infection in identical twins. Pediatrics. Mar 2008;121:493–496. doi: 10.1542/peds.2007-1889. [DOI] [PubMed] [Google Scholar]
  • 2.Awomoyi AA, Rallabhandi P, Pollin TI. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol. 2007;179:3171–3177. doi: 10.4049/jimmunol.179.5.3171. [DOI] [PubMed] [Google Scholar]
  • 3.Paulus SC, Hirschfeld AF, Victor RE, Brunstein J, Thomas E, Turvey SE. Common human Toll-like receptor 4 polymorphisms–role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin Immunol. 2007;123:252–257. doi: 10.1016/j.clim.2007.03.003. [DOI] [PubMed] [Google Scholar]
  • 4.Puthothu B, Krueger M, Forster J, Heinze J, Weckmann M, Heinzmann A. Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J. 2007;26:1094–1098. doi: 10.1097/INF.0b013e3181453579. [DOI] [PubMed] [Google Scholar]
  • 5.Amanatidou V, Sourvinos G, Apostolakis S. RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis. Pediatr Infect Dis J. 2008;27:38–42. doi: 10.1097/INF.0b013e31814d4e42. [DOI] [PubMed] [Google Scholar]
  • 6.Janssen R, Bont L, Siezen CL. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007;196:826–834. doi: 10.1086/520886. [DOI] [PubMed] [Google Scholar]
  • 7.Helminen M, Nuolivirta K, Virta M. IL-10 gene polymorphism at −1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr Pulmonol. 2008;43:391–395. doi: 10.1002/ppul.20793. [DOI] [PubMed] [Google Scholar]
  • 8.Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol. 2007;119:1086–1091. doi: 10.1016/j.jaci.2006.12.655. [DOI] [PubMed] [Google Scholar]
  • 9.Robinson JL, Lee BE, Kothapalli S, Craig WR, Fox JD. Use of throat swab or saliva specimens for detection of respiratory viruses in children. Clin Infect Dis. 2008;46:e61–e64. doi: 10.1086/529386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Aslanzadeh J, Zheng X, Li H. Prospective evaluation of rapid antigen tests for diagnosis of respiratory syncytial virus and human metapneumovirus infections. J Clin Microbiol. 2008;46:1682–1685. doi: 10.1128/JCM.00008-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bosis S, Esposito S, Niesters HG. Role of respiratory pathogens in infants hospitalised for a first episode of wheezing and their impact on recurrences. Clin Microbiol Infect. 2008;14:677–684. doi: 10.1111/j.1469-0691.2008.02016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Puig C, Sunyer J, Garcia-Algar O. Incidence and risk factors of lower respiratory tract illnesses during infancy in a Mediterranean birth cohort. Acta Paediatr. 2008;97:1406–1411. doi: 10.1111/j.1651-2227.2008.00939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Canducci F, Debiaggi M, Sampaolo M. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716–723. doi: 10.1002/jmv.21108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cambonie G, Milesi C, Jaber S. Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Med. 2008;34:1865–1872. doi: 10.1007/s00134-008-1201-x. [DOI] [PubMed] [Google Scholar]
  • 15.Berner ME, Hanquinet S, Rimensberger PC. High frequency oscillatory ventilation for respiratory failure due to RSV bronchiolitis. Intensive Care Med. 2008;34:1698–1702. doi: 10.1007/s00134-008-1151-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kneyber MC, van Woensel JB, Uijtendaal E, Uiterwaal CS, Kimpen JL. Azithromycin does not improve disease course in hospitalised infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomised equivalence trial. Pediatr Pulmonol. 2008;43:142–149. doi: 10.1002/ppul.20748. [DOI] [PubMed] [Google Scholar]
  • 17.Chen CH, Lin YT, Yang YH. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitisation. Pediatr Allergy Immunol. 2008;19:166–172. doi: 10.1111/j.1399-3038.2007.00610.x. [DOI] [PubMed] [Google Scholar]
  • 18.Simon A, Ammann RA, Wilkesmann A. Respiratory syncytial virus infection in 406 hospitalised premature infants: results from a prospective German multicentre database. Eur J Pediatr. 2007;166:1273–1283. doi: 10.1007/s00431-007-0426-y. [DOI] [PubMed] [Google Scholar]
  • 19.Okiro EA, Ngama M, Bett A, Cane PA, Medley GF, James Nokes D. Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children. Trop Med Int Health. 2008;13:914–926. doi: 10.1111/j.1365-3156.2008.02092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kusel MM, de Klerk NH, Kebadze T. Early-life respiratory viral infections, atopic sensitisation, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119:1105–1110. doi: 10.1016/j.jaci.2006.12.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi MO. Lung function and bronchial hyper-responsiveness 11 years after hospitalisation for bronchiolitis. Acta Paediatr. 2007;96:1464–1469. doi: 10.1111/j.1651-2227.2007.00458.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Paediatric Respiratory Reviews are provided here courtesy of Elsevier

RESOURCES